Cargando…
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832356/ https://www.ncbi.nlm.nih.gov/pubmed/32807652 http://dx.doi.org/10.1016/j.transci.2020.102904 |
| _version_ | 1783641819776548864 |
|---|---|
| author | Tatar, Erhan Karatas, Murat Bozaci, Ilter Ari, Alpay Acar, Turker Simsek, Cenk Yildirim, Ali Murat Yildirim, Ozden Uslu, Adam |
| author_facet | Tatar, Erhan Karatas, Murat Bozaci, Ilter Ari, Alpay Acar, Turker Simsek, Cenk Yildirim, Ali Murat Yildirim, Ozden Uslu, Adam |
| author_sort | Tatar, Erhan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7832356 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78323562021-01-26 Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia Tatar, Erhan Karatas, Murat Bozaci, Ilter Ari, Alpay Acar, Turker Simsek, Cenk Yildirim, Ali Murat Yildirim, Ozden Uslu, Adam Transfus Apher Sci Letter to the Editor Elsevier Ltd. 2020-12 2020-08-03 /pmc/articles/PMC7832356/ /pubmed/32807652 http://dx.doi.org/10.1016/j.transci.2020.102904 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Tatar, Erhan Karatas, Murat Bozaci, Ilter Ari, Alpay Acar, Turker Simsek, Cenk Yildirim, Ali Murat Yildirim, Ozden Uslu, Adam Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| title | Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| title_full | Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| title_fullStr | Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| title_full_unstemmed | Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| title_short | Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
| title_sort | intravenous immunoglobulin and favipiravir treatment for a kidney transplant patient with severe covid-19 pneumonia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832356/ https://www.ncbi.nlm.nih.gov/pubmed/32807652 http://dx.doi.org/10.1016/j.transci.2020.102904 |
| work_keys_str_mv | AT tatarerhan intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT karatasmurat intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT bozaciilter intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT arialpay intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT acarturker intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT simsekcenk intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT yildirimalimurat intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT yildirimozden intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia AT usluadam intravenousimmunoglobulinandfavipiravirtreatmentforakidneytransplantpatientwithseverecovid19pneumonia |